$JANX
Janux Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$18.50
▲+10.18%+$1.71
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateJanux Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is JANX up today? It is at $18.50 (+10.18%), and our scanner flagged it 35 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment JANX spikes, and full due diligence on JANX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $JANX 35 times in the last 30 days. Create a free account to track $JANX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
JANX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 4 unusual-volume and momentum alerts on JANX today. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystJanux Therapeutics, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filingSC 13G/APassive 5%+ stake updatedAug 14, 2026 · 54 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Campbell David Alan Officer | Sold (automatic/other) | -124K 0.2% of company | sold 32% | 265K | n/a | Jul 31, 26 |
Campbell David Alan Officer | Other | 7K 0.01% of company | added 1.8% | 389K | $29K at $4.21 | Jul 8, 26 |
Barrett Ronald W Director | Acquired (grant/award) | +6K | added 88% | 12K | n/a | Jun 11, 26 |
Dobmeier Eric Director | Acquired (grant/award) | +6K | added 55% | 15K | n/a | Jun 11, 26 |
Capps Vickie L Director | Acquired (grant/award) | +6K | added 7.4% | 80K | n/a | Jun 11, 26 |
Kung Winston Director | Acquired (grant/award) | +6K | added 88% | 12K | n/a | Jun 11, 26 |
Hernday Natasha Director | Acquired (grant/award) | +6K | added 55% | 15K | n/a | Jun 11, 26 |
Simson Jake Director | Acquired (grant/award) | +6K | added 88% | 12K | n/a | Jun 11, 26 |
Ra Capital Management, L.P. Director | Acquired (grant/award) | +6K | added <0.1% | 11.20M | n/a | Jun 11, 26 |
Doyle Janeen Noel Officer | Sold (automatic/other) | -4K | sold 5.1% | 76K | $57K at $14.03 | Jun 2, 26 |
Dobek Maria Officer | Sold (automatic/other) | -2K | sold 5.9% | 32K | $29K at $14.17 | May 11, 26 |
Go William Officer | Acquired (grant/award) | +44K 0.07% of company | n/a | 44K | n/a | Feb 2, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
JANX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 4 unusual-volume and momentum alerts on JANX today. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
JANX last traded at $18.50, up 10.18% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Janux Therapeutics, Inc. Common Stock (JANX) is next expected to report earnings on Thursday, November 5, 2026, about 29 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The JANX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged JANX 35 times in the last 30 days.
JANX (Janux Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $1.03B in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge JANX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$JANX discussion
Sign in to ask a question or join the discussion.